Latest Leverage News

Motio Limited has raised $1.73 million through a placement to accelerate its digital display network expansion and repay debt early, aiming to reach profitability sooner.

Aeris Resources has announced a maiden open pit Probable Ore Reserve for its Constellation Project in New South Wales, underpinning a 5-to-7-year mine life and leveraging existing Tritton processing infrastructure.

SQX Resources is set to acquire an 80% stake in AM6 Pty Ltd, gaining control of high-grade gold and silver projects in Montana and Arizona, with drilling programs slated to commence in December 2025.

Anteris Technologies has enrolled the first patients in its pivotal PARADIGM Trial, testing the DurAVR Transcatheter Heart Valve against leading competitors in a global study.

Felix Group Holdings has completed its strategic acquisition of Nexvia, boosting its vendor monetisation capabilities and reporting a 17% increase in Enterprise ARR for Q1 FY26. The company also secured new contracts in North America, signalling promising international growth.

Rokeby Resources has confirmed significant gold and antimony mineralisation across multiple prospects at its Hurricane Project in North Queensland, following its maiden drilling campaign. The company secured $1.7 million in an oversubscribed placement to advance Phase 2 drilling and exploration.

Lincoln Minerals has identified promising new drill targets at its Minbrie Copper-Base Metals Project in South Australia and secured $2.25 million in funding to advance exploration activities.

Element 25 Limited has raised AU$10 million to advance its Butcherbird Expansion Project in Western Australia, aiming to increase manganese production and support its innovative battery materials refinery in the US.

Gold Hydrogen Limited has closed a $14.5 million strategic investment round led by Toyota, Mitsubishi Gas Chemical, and ENEOS Xplora, positioning the company to accelerate drilling and commercialisation efforts at its Ramsay Project in South Australia.

Uvre Limited has completed a strategic acquisition of New Zealand gold projects, commenced maiden drilling at its flagship Waitekauri site, and secured a dual listing on the NZX, positioning itself for significant exploration advances.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.

Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.